Title : Efficacy and safety of PD-1/PD-L1 inhibitors plus nab-paclitaxel for patients with non-small cell lung cancer who have progressed after platinum-based chemotherapy.

Pub. Date : 2020

PMID : 32670420






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Conclusion: PD-1/PD-L1 inhibitor plus nab-paclitaxel resulted in significantly longer OS and higher response versus ICI single agent in metastatic NSCLC patients who have progressed after platinum-based chemotherapy. Platinum CD274 molecule Homo sapiens